-
Signature
-
/s/ Chad A. Keetch, as power of attorney
-
Issuer symbol
-
ENSG
-
Transactions as of
-
15 May 2025
-
Net transactions value
-
-$474,934
-
Form type
-
4
-
Filing time
-
19 May 2025, 17:14:02 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Wittekind Beverly B. |
VP and Chief Legal Officer |
29222 RANCHO VIEJO ROAD, SUITE 127, SAN JUAN CAPISTRANO |
/s/ Chad A. Keetch, as power of attorney |
19 May 2025 |
0001475842 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ENSG |
Common Stock |
Award |
$0 |
+1,000 |
+2.6% |
$0.000000 |
39,209 |
15 May 2025 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Options Exercise |
$55,916 |
+3,539 |
+9% |
$15.80 |
42,748 |
16 May 2025 |
Direct |
F2 |
| transaction |
ENSG |
Common Stock |
Sale |
$530,850 |
-3,539 |
-8.3% |
$150.00 |
39,209 |
16 May 2025 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Award |
$0 |
+2,500 |
|
$0.000000 |
2,500 |
15 May 2025 |
Common Stock |
2,500 |
$147.04 |
Direct |
F3 |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-3,539 |
-100% |
$0.000000 |
0 |
16 May 2025 |
Common Stock |
3,539 |
$15.80 |
Direct |
F2, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: